These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
664 related articles for article (PubMed ID: 10215908)
1. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908 [TBL] [Abstract][Full Text] [Related]
2. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Rosenblad C; Kirik D; Björklund A Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072 [TBL] [Abstract][Full Text] [Related]
3. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Kirik D; Rosenblad C; Björklund A Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582 [TBL] [Abstract][Full Text] [Related]
4. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. Horger BA; Nishimura MC; Armanini MP; Wang LC; Poulsen KT; Rosenblad C; Kirik D; Moffat B; Simmons L; Johnson E; Milbrandt J; Rosenthal A; Bjorklund A; Vandlen RA; Hynes MA; Phillips HS J Neurosci; 1998 Jul; 18(13):4929-37. PubMed ID: 9634558 [TBL] [Abstract][Full Text] [Related]
5. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829 [TBL] [Abstract][Full Text] [Related]
6. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Aoi M; Date I; Tomita S; Ohmoto T Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. Akerud P; Alberch J; Eketjäll S; Wagner J; Arenas E J Neurochem; 1999 Jul; 73(1):70-8. PubMed ID: 10386956 [TBL] [Abstract][Full Text] [Related]
8. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. Oiwa Y; Yoshimura R; Nakai K; Itakura T Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170 [TBL] [Abstract][Full Text] [Related]
9. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum. Cass WA; Peters LE Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442 [TBL] [Abstract][Full Text] [Related]
10. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. Winkler C; Sauer H; Lee CS; Björklund A J Neurosci; 1996 Nov; 16(22):7206-15. PubMed ID: 8929429 [TBL] [Abstract][Full Text] [Related]
11. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Wang Y; Tien LT; Lapchak PA; Hoffer BJ Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891 [TBL] [Abstract][Full Text] [Related]
12. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166 [TBL] [Abstract][Full Text] [Related]
13. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Georgievska B; Kirik D; Björklund A Exp Neurol; 2002 Oct; 177(2):461-74. PubMed ID: 12429192 [TBL] [Abstract][Full Text] [Related]
14. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Rosenblad C; Martinez-Serrano A; Björklund A Neuroscience; 1998 Jan; 82(1):129-37. PubMed ID: 9483509 [TBL] [Abstract][Full Text] [Related]
15. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Sullivan AM; Opacka-Juffry J; Blunt SB Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113 [TBL] [Abstract][Full Text] [Related]
16. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076 [TBL] [Abstract][Full Text] [Related]
18. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Kirik D; Georgievska B; Rosenblad C; Björklund A Eur J Neurosci; 2001 Apr; 13(8):1589-99. PubMed ID: 11328352 [TBL] [Abstract][Full Text] [Related]
19. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery. Lapchak PA; Miller PJ; Collins F; Jiao S Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089 [TBL] [Abstract][Full Text] [Related]
20. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats. Lu X; Hagg T J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]